News
Just 5% of pediatric providers feel highly confident in evaluating and managing neuropsychiatric SLE in youth.
18h
GlobalData on MSNCullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trialThe trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.
Research into Sjögren’s disease — both analyzing the condition itself and testing potential treatments — has come a long way ...
FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...
OMRF opens Center for Biomedical Data Sciences to boost AI-driven research on diseases like lupus and Alzheimer’s across ...
Plump, pouty lips are everywhere—from social media filters to celebrity red carpets. But behind the glossy aesthetic of lip ...
Market Overview: The North American autoimmune disease diagnostics market encompasses a wide range of diseases, including rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. These ...
Rheumatoid arthritis (RA) and lupus both cause joint pain and stiffness. Despite some similarities, it’s easy for doctors to distinguish them. RA has more debilitating effects on the joints.
A novel method combining EHR and GWAS data improves prediction of autoimmune disease progression from preclinical stages, ...
Researchers who discovered a mechanism that prevents B cells from attacking the body’s own tissues in autoimmune diseases win ...
Systemic sclerosis, or scleroderma, causes the hardening of skin and connective tissues. Often, the disease harms other ...
Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 7.23%, which has investors questioning if this is right time to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results